
Medical Device Manufacturer

Recently, Medtronic stated in a filing with the U.S. Securities and Exchange Commission that Rob ten Hoedt, Executive Vice President and President of Global Regions at Medtronic, will retire on June 28. Ten Hoedt, who is also a member of Medtronic's Executive Committee, submitted his retirement notice on June 1.

01
Global Vice President, Key Node Retirement
According to a filing with the U.S. Securities and Exchange Commission, he turned 63 on April 28. In recent years, Medtronic has set a mandatory retirement age of 65 for departing executives, such as former CEO Omar Ishrak, former Executive Vice President and General Counsel Brad Lerman, and former Chief Medical and Scientific Officer Dr. Rick Kuntz.

Ten Hoedt's departure comes amid significant changes at Medtronic, which has implemented a series of management initiatives such as shutting down its ventilator business, layoffs and an early retirement plan last year, strengthening spending discipline, and increasing the use of automation and digitalization.At the same time, the company said it has made strategic R&D investments to support future growth.
Foreign media stated that they have contacted Medtronic for more information regarding ten Hoedt's retirement, including who will succeed him, but so far, Medtronic has not disclosed the successor.
02
One of the largest shareholders, driving continuous growth of core products
The company said on its website that, as the president of the Global Regions,ten Hoedt is fully responsible for Medtronic's product development and market in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.This includes the ongoing development of the Hugo surgical robot system, a project that began after Medtronic acquired Covidien in 2015 for a substantial $43 billion.Hugo received the CE mark in the EU in 2021.
"In the press release announcing that Medtronic's Hugo received the CE mark, he stated, 'Robotics and artificial intelligence are an undeniable part of the future of healthcare, with tremendous potential not only to enhance patient care but also to reduce reliance on physicians’ technical skills.'"
Medtronic's Hugo system has not yet received FDA approval, but the company stated last month that it is conducting more clinical studies to support submission for FDA review.

Image Source: Official Website
Medtronic transferred last yearTen Hoedt was ranked as one of the highest-paid executives in the company, with a total compensation of $5 million for the 2023 fiscal year.
According to a document filed with the U.S. Securities and Exchange Commission (SEC),He is also one of the largest individual shareholders of Medtronic.As of August 2023, he held approximately 540,000 shares. The document at the time listed only two executives who held more shares:Chairman and Chief Executive Officer Geoff MarthaHold7.95 million sharesBob White, former Executive Vice President and President of the Medical Surgical Portfolio, holds 623,000 shares.
Bob White (whose Medical Surgical Portfolio includes Hugo) also retired this year. Martha announced the complete shutdown of the ventilator business during the company’s Q3 earnings call in February. She simultaneously announced that Bob White, Executive Vice President and President of the Medical Surgical Portfolio, would be leaving the company as part of a new round of restructuring.

Bob White
That isHe successfully led the acquisition of Medtronic and Covidien.And complete the integration in the Asia-Pacific region, bringing together more than 5,000 employees as one team.
Since Ten Hoedt's announcement, Medtronic has not held an earnings call, and the company does not appear to have publicly discussed his upcoming departure.
03
Rob ten Hoedt's Medtronic Career
At the age of 18, ten Hoedt visited the hospital after experiencing a "rather terrifying accident," which marked the beginning of his career.
"Although that experience was terrifying, everything that happened in the hospital left a deep impression on me — the doctors, nurses, care, all the progress," he said in a 2014 interview with the U.S. Securities and Exchange Commission, as Medtronic was completing its acquisition of Covidien. "He recalled lying in bed, staring at the ceiling, and thinking, I know this is my destiny; I want to do something in the healthcare field."
"I come from Europe, and as far as I know, Europe has always implemented a socialized healthcare system," he continued. "But these systems are now getting into very complicated situations. The government can no longer afford it, the demand is too great, and it's time to change healthcare. I hope my children and grandchildren can receive the same medical services as I do. I think as a new company we can support these systems in a valuable way, with economic value, and have the opportunity to participate in providing medical services, supporting systems, holistic solutions, services, and solutions. I believe that now, in our new company, we have the opportunity to change healthcare for our future and for our children."
04
Medtronic, at a time of significant transformation
01
Early Retirement
In March 2023, Medtronic launched a voluntary early retirement incentive program in an effort to complete a significant cost-cutting plan before the end of the fourth quarter. In a public statement, Medtronic described the Voluntary Early Retirement Program (VERP) as a "limited opportunity for early retirement with enhanced benefits," and also as a way for the company to avoid layoffs. Compared to large-scale layoffs, this approach can also reduce unemployment, severance payments, and litigation costs.
02
Shut Down Ventilator Business
03
Executive Departure
04
Layoffs







